Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
Salinomycin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/07/2021 5 1
Fluoxetine  Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/15/2021 4 0
Maduramicin Potential treatment - pre-clinical evidence Experimental Antiviral Jan/15/2021 2 0
Nanchangamycin Potential treatment - pre-clinical evidence Natural product Antiviral Nov/25/2020 1 0
Narasin Potential treatment - pre-clinical evidence Experimental Antiviral Nov/25/2020 1 0
X-206 Potential treatment - pre-clinical evidence Experimental Antiviral Nov/25/2020 1 0
Monensin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/25/2020 2 0
Lenzilumab Potential treatment - clinical evidence Experimental Other treatment Nov/01/2020 2 0
EY6A Potential treatment - pre-clinical evidence Experimental Antiviral Jun/13/2020 1 0
Excel (.xslx) CSV (.csv)